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A B S T R A C T
Down syndrome (DS) is caused by triplication of chromosome 21 (HSA21). It is characterised by intellectual
disability and impaired motor coordination that arise from changes in brain volume, structure and function.
However, the contribution of each HSA21 gene to these various phenotypes and to the causal alterations in
neuronal and synaptic structure and function are largely unknown. Here we have investigated the eﬀect of
overexpression of the HSA21 gene DSCAM (Down syndrome cell adhesion molecule), on glutamatergic synaptic
transmission and motor coordination, using Drosophila expressing three copies of Dscam1. Electrophysiological
recordings of miniature and evoked excitatory junction potentials at the glutamatergic neuromuscular junction
of Drosophila larvae showed that the extra copy of Dscam1 changed the properties of spontaneous and elec-
trically-evoked transmitter release and strengthened short-term synaptic depression during high-frequency ﬁring
of the motor nerve. Behavioural analyses uncovered impaired locomotor coordination despite preserved gross
motor function. This work identiﬁes DSCAM as a candidate causative gene in DS that is suﬃcient to modify
synaptic transmission and synaptic plasticity and cause a DS behavioural phenotype.
1. Introduction
Down syndrome (DS, also known as Down's syndrome) is caused by
triplication of all or part of human chromosome 21 (HSA21; trisomy 21,
OMIM ID: 190685) (Antonarakis, 2016) and occurs in 1 in ~900 live
births (de Graaf et al., 2017; Wu and Morris, 2013). DS is characterised
by mild to severe intellectual disability (Lott and Dierssen, 2010),
motor impairments (Malak et al., 2013; Rao et al., 2017), and early
onset dementia that is a form of Alzheimer's disease (Ballard et al.,
2016; Hithersay et al., 2017). These clinical features are accompanied
by changes in the number and structure of brain neurons and synapses,
as well as changes in the concentrations of the neurotransmitters, GABA
and glutamate, and their receptors (Contestabile et al., 2017; Dierssen,
2012; Rueda et al., 2012). The cognitive and motor deﬁcits in DS arise
from aberrant information processing in the brain that is due, in part, to
changes in synaptic transmission or synaptic plasticity. Individuals with
DS have impaired synaptic plasticity in the motor cortex (Battaglia
et al., 2008). In cultured neurons derived from trisomy 21 induced
pluripotent stem cells, the extra copy of HSA21 results in fewer ex-
citatory and inhibitory connections, as well as a decrease in the fre-
quency of spontaneous excitatory and inhibitory postsynaptic currents
(sEPSCs and sIPSCs) (Weick et al., 2013).
How synaptic transmission and plasticity are changed in the brain
by triplication of HSA21 genes has also been investigated in a variety of
mouse models of DS that express a third copy of diﬀerent numbers of
HSA21 mouse orthologues (including Ts65Dn, Ts1Rhr, Ts1Cje, Ts2Cje,
Ts1Yah, Dp(16)1Yey/+, Dp(10)1Yey/+;Dp(16)1Yey/+;Dp(17)1Yey/
+) or a human chromosome 21 (Tc1). These electrophysiological stu-
dies have revealed alterations in basal synaptic transmission at some
brain synapses. In cultured hippocampal neurons, miniature EPSCs
(mEPSCs) have a faster rise and decay (Best et al., 2008). In CA3
neurons in hippocampal slices, there is a decrease in the frequency of
both miniature IPSCs (mIPSCs) and mEPSCs (Hanson et al., 2007;
Stagni et al., 2013) alongside a decrease in mIPSC amplitude and no
change in long term potentiation (LTP) of evoked excitatory transmis-
sion (Hanson et al., 2007). Likewise, in neocortical neurons, sIPSCs and
sEPSCs are less frequent but sEPSC amplitudes are reduced (Cramer
et al., 2015). In cerebellar slices, evoked EPSCs at parallel ﬁbre-Pur-
kinje cell synapses, but not at climbing ﬁbre-Purkinje cell synapses, are
slower (Galante et al., 2009) or unchanged (Das et al., 2013), and long-
term depression (LTD) at parallel ﬁbre-Purkinje cell synapses is un-
altered (Das et al., 2013; Galante et al., 2009). The probability of
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glutamate release from cerebellar granule cells is enhanced (Das et al.,
2013) and these neurons receive weaker tonic GABAergic inhibition
(Szemes et al., 2013). Other studies have identiﬁed alterations in sy-
naptic plasticity at some excitatory glutamatergic brain synapses. LTP
and LTD in striatal spiny neurons are unaﬀected, but LTP is decreased
in striatal cholinergic interneurons (Di Filippo et al., 2010). Extra-
cellular recordings of ﬁeld EPSPs report weaker LTP but stronger LTD at
excitatory synapses on CA1 neurons, due to enhanced GABAergic
transmission (Andrade-Talavera et al., 2015; Belichenko et al., 2007;
Chakrabarti et al., 2010; Costa and Grybko, 2005; Das et al., 2013;
Deidda et al., 2015; Kaur et al., 2014; Mitra et al., 2012; Olson et al.,
2007; Pereira et al., 2009; Siarey et al., 1999; Siarey et al., 1997; Siarey
et al., 2005; Yu et al., 2010a; Yu et al., 2010b; Zhang et al., 2014),
which may include an increase in excitatory, as well as inhibitory,
GABAergic signalling mediated by GABAA or GABAB receptors
(Contestabile et al., 2017; Deidda et al., 2015). Extracellular recordings
of ﬁeld EPSPs also report impaired LTP in synapses of the dentate gyrus
(DG) and perirhinal cortex, due to enhanced GABAergic transmission
(Belichenko et al., 2009; Belichenko et al., 2015; Contestabile et al.,
2013; Fernandez et al., 2007; Kleschevnikov et al., 2012; Kleschevnikov
et al., 2004; Morice et al., 2008; O'Doherty et al., 2005; Roncace et al.,
2017). Although weaker LTP at hippocampal CA1 and DG synapses has
largely been ascribed to enhanced GABAergic signalling (Contestabile
et al., 2017), some studies report compromised glutamate release in
response to closely spaced pairs or trains of stimuli at DG synapses
(Kaur et al., 2014) and CA1 synapses (Andrade-Talavera et al., 2015;
Siarey et al., 2005), that may contribute to the weaker LTP.
Altogether, the electrophysiological studies indicate that synaptic
dysfunction in DS is not the same at all brain synapses, and both glu-
tamatergic and GABAergic transmission can be altered. The contribu-
tion of individual HSA21 genes to the changes in synaptic function in
DS is incompletely understood (Gupta et al., 2016). One way to explore
this gene-phenotype relationship, that is faster and less costly than
using mouse models, is to overexpress individual orthologous genes in
Drosophila and examine their consequences (Chang and Min, 2009;
Cvetkovska et al., 2013). Drosophila is an established model of genetic
disorders due to its short lifespan, well deﬁned neural circuits, genetic
tractability, conservation of molecular mechanisms driving cellular and
physiological processes, and the existence of Drosophila orthologues for
~75% of disease causing human genes (Androschuk et al., 2015;
Perrimon et al., 2016; Ugur et al., 2016). One candidate HSA21 gene for
such a study is Down syndrome cell adhesion molecule (DSCAM).
DSCAM is a member of the immunoglobulin superfamily with four
Drosophila homologues, Dscam1–4 (Tadros et al., 2016), of which
Dscam1 is the prototypical member and the most studied. In both
Drosophila and mice, Dscam is highly expressed throughout the central
and peripheral nervous system (Barlow et al., 2002; Barlow et al., 2001;
Wang et al., 2004), in a highly regulated spatiotemporal pattern (Saito
et al., 2000; Yamakawa et al., 1998), and is locally translated in den-
drites and growth cones (Alves-Sampaio et al., 2010; Jain and
Welshhans, 2016). Loss of function studies have uncovered a vital role
for DCSAM in the structural development of the nervous system that is
conserved from Drosophila to mammals. It is necessary for self-avoid-
ance during neurite outgrowth (de Wit and Ghosh, 2016; Fuerst et al.,
2009; Hutchinson et al., 2014), normal dendritic branching and spine
formation (de Andrade et al., 2014; Maynard and Stein, 2012; Zhang
et al., 2015; Zhu et al., 2006), correct axon targeting (Cvetkovska et al.,
2013; Hutchinson et al., 2014; Liu et al., 2009) and the formation of
synapses (Hummel et al., 2003; Li et al., 2009; Millard et al., 2010).
Dscam also regulates clustering of postsynaptic AMPA-like ionotropic
glutamate receptors in Aplysia neurons (Li et al., 2009), and is essential
for the correct operation of locomotor and sensorimotor circuits that
underpin locomotor coordination and motor learning in mice (Lemieux
et al., 2016; Thiry et al., 2016; Xu et al., 2011). Overexpression of
murine Dscam in mice increases cell death and disrupts dendrite tar-
geting in the retina (Li et al., 2015), promotes axonal growth of retinal
ganglion cells (Bruce et al., 2017) and disrupts dendritic and axonal
branching in mouse cultured hippocampal or cortical neurons (Alves-
Sampaio et al., 2010; Jain and Welshhans, 2016). Overexpression of
Dscam in Drosophila causes abnormal branching of sensory axons and
impaired transfer of information along the neural circuit mediating
touch perception (Cvetkovska et al., 2013) and enlargement of pre-
synaptic terminals of sensory neurons in Drosophila larvae (Kim et al.,
2013). Altogether, these studies indicate that the eﬀects of DSCAM are
gene dosage sensitive.
The extra copy of HSA21 in DS causes overexpression of DSCAM in
the brain from childhood to adulthood, particularly in cerebral cortical
neurons, cerebellar Purkinje cells and ﬁbres in the cerebellar granule
layer (Saito et al., 2000). Dscam overexpression is replicated in hippo-
campal and cerebral neurons, and in the whole-brain of mouse models
of DS (Alves-Sampaio et al., 2010; Amano et al., 2004; Guedj et al.,
2015; Perez-Nunez et al., 2016), wherein it disrupts dendritic growth
(Perez-Nunez et al., 2016). Dscam is also overexpressed in mice that
overexpress another HSA21 gene orthologue App, which encodes the
amyloid precursor protein (Jia et al., 2011) and is a causative gene in
cognitive dysfunction in DS and Alzheimer's Disease (Wiseman et al.,
2015). Dosage sensitivity of the eﬀects of DSCAM in DS is supported by
the ability of Dscam loss of function mutations to correct the disrupted
dendritic fasciculation of a subset of retinal ganglion cells in the Ts65Dn
mouse model of DS (which has three copies of a chromosomal segment
orthologous to a HSA21 segment that contains DSCAM) (Blank et al.,
2011). In contrast, this normalisation of Dscam copy number did not
correct the enhanced ipsi/contralateral segregation of retinogeniculate
projections observed in Ts65Dn mice, suggesting an essential role for
other triplicated genes in this phenotype (Blank et al., 2011).
As outlined above, many studies have shown that DSCAM shapes
dendritic, axonal and synaptic structure in a dose-dependent manner;
many of the dose-dependent physical changes predict changes in sy-
naptic communication. The elevated DSCAM expression in DS cere-
bellar Purkinje cells and ﬁbres in the cerebellar granule layer (Saito
et al., 2000) suggests a role in motor deﬁcits in DS; the ﬁbres convey
information to the Purkinje cells, which integrate the information and
carry signals out of the cerebellar cortex to direct motor planning, ex-
ecution and coordination (Apps and Garwicz, 2005). As there have been
no direct studies of the eﬀects of DSCAM overexpression on synaptic
transmission or plasticity or motor function, we investigated the eﬀects
of a third copy of DSCAM on glutamatergic synaptic transmission and
locomotor function. We took advantage of a previously described Dro-
sophila model that expresses a third copy of Dscam1 (hereafter
Dscamx3) under its endogenous promoter and has elevated levels of
Dscam1 mRNA and Dscam1 protein (Cvetkovska et al., 2013). Synaptic
transmission and short-term plasticity were examined at the larval
NMJ, a glutamatergic synapse that is considered an excellent model of
mammalian central glutamatergic synapses and is readily accessible for
electrophysiological recording (Harris and Littleton, 2015; Menon
et al., 2013). Locomotor function of larvae was assessed in two beha-
vioural assays.
2. Materials and methods
2.1. Drosophila strains
Flies were raised with a 12 h:12 h light dark (LD) cycle with lights
on at ZT 0 (Zeitgeber Time) on standard Drosophilamedium (0.7% agar,
1.0% soya ﬂour, 8.0% polenta/maize, 1.8% yeast, 8.0% malt extract,
4.0% molasses, 0.8% propionic acid, 2.3% nipagen) at 25 °C and col-
lected ~6 days after egg laying. Canton Special white- (CSw-), from Dr.
Scott Waddell (University of Oxford) were used as a control. Flies with
three copies of Dscam (Dscamx3) were generated by crossing homo-
zygous Dscam1BAC ﬂies (Cvetkovska et al., 2013), which contain an
extra copy of the full length of the Dscam1 gene in a bacterial artiﬁcial
chromosome, to CSw- ﬂies, to generate heterozygous oﬀspring
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containing one extra copy. The Dscam1BAC ﬂies were kindly donated by
Dr. Brian Chen (McGill University Health Centre) and have previously
been veriﬁed to overexpress Dscam1 mRNA and Dscam1 protein
(Cvetkovska et al., 2013).
2.2. Behaviour
For the free-crawling assay, a single third instar wandering larva
was washed in a drop of distilled H2O, transferred to a 9.5 cm dish
containing 1.6% agarose and allowed 30 s to acclimatise. The dish was
placed over a 0.5 cm grid and the number of lines the larva crossed in
one minute was counted. For the self-righting assay, a larva was gently
rolled onto its back using a ﬁne distilled H2O-moistened paintbrush and
the time for it to right itself was recorded (Park et al., 2002). Experi-
ments took place at 25 °C.
2.3. Antibody staining and visualisation
Wandering third instar larvae were dissected in ice-cold, Ca2+-free
HL3.1-like solution (in mM: 70 NaCl, 5 KCl, 10 NaHCO3, 115 sucrose, 5
trehalose, 5 HEPES, 10 MgCl2) to produce a larval “ﬁllet” (Brent et al.,
2009). The ﬁllet was ﬁxed for 30 min in 4% paraformaldehyde (Sigma
Labs) and washed three times in 1% Triton-X (Sigma Labs), then
blocked for one hour in 5% normal goat serum (Fitzgerald Industries)
and 1% Triton-X at room temperature. It was incubated overnight in
1:500 FITC-conjugated anti-horseradish peroxidase (HRP-FITC)
(Jackson Immunoresearch Laboratories) and 1:500 mouse anti-Discs
large (Dlg) primary antibody (Sherwood et al., 2004), then for two
hours in 1:500 AlexaFluor 633-conjugated goat anti-mouse secondary
antibody at room temperature. Fillets were washed and mounted on a
coverslip in Vectashield (Vector Laboratories). Z-series of larval NMJs
were imaged on a Leica SP5-II confocal laser-scanning microscope using
an oil immersion 40× objective. The number of boutons at the NMJ of
muscle 6/7 in segment A2 was counted manually. Satellite boutons
were identiﬁed as a single bouton with 3 or more boutons budding from
it (Menon et al., 2013). ImageJ (rsb.info.nih.gov/ij/) was used to
manually outline muscles 6 and 7 and hence calculate their area.
2.4. Electrophysiology
Wandering third instar larvae were dissected in ice-cold, Ca2+-free
HL3.1-like solution, as for antibody staining, then the motor nerves
were severed below the ventral ganglion and the brain was removed.
CaCl2 (1 mM) was added to the bath solution for intracellular recording
from muscle 6 of abdominal segments 2–4. Sharp microelectrodes
(thick-walled borosilicate glass capillaries, pulled on a Sutter Flaming/
Brown P-97 micropipette puller) were ﬁlled with 3 M KCl and had re-
sistances of 20–30 MΩ. For recording of stimulus evoked excitatory
junction potentials (EJPs), severed nerves were drawn into a thin-
walled glass-stimulating pipette and stimulated 10 times with square-
wave voltage pulses (0.1 ms, 10 V, A-M Systems Model 2100 Isolated
Pulse Simulator) at a frequency of 0.1 Hz.
EJPs and spontaneously-occurring miniature EJPs (mEJPs) were
recorded from muscle 6, segments A2–4, at a controlled room tem-
perature of 22–25 °C with a Geneclamp 500 ampliﬁer (Axon
Instruments) and were further ampliﬁed with a LHBF-48× ampliﬁer
(NPI Electronic). The membrane potential was set to −70 mV with
current input at the start of the recording. Voltage signals were low-pass
ﬁltered at 1.67 kHz (10 kHz 4 pole Bessel on Geneclamp 500, 1.7 kHz 8-
pole Bessel on LHBF-48x) and digitised at 25 kHz by a CED-1401 plus
A/D interface (Cambridge Electronic Design, UK) using Spike2 software
(v. 5.13) (CED, Cambridge, UK). Synaptic potentials were analysed oﬀ
line using Strathclyde Electrophysiology Software WinEDR (v3.5.2) and
GraphPad Prism (v.6). All synaptic events were veriﬁed manually.
Recordings were discarded if the initial resting membrane potential
was more positive than−60 mV or varied by> 10% during recording
for at least 20 min. The input resistance of the muscle was measured by
injecting current using the Axon Geneclamp 500, to bring the mem-
brane potential to−100,−80,−60 and−40 mV and subtracting the
electrode resistance from the slope of the resulting voltage/current
graph. There was no diﬀerence between control and Dscamx3 larval
NMJs in mean resting membrane potential (CSw-,−69.00 ± 2.33 mV,
N= 8; Dscamx3, −71.38 ± 1.87 mV, N= 8; P= 0.439) or input
resistance (CSw-, 3.16 ± 0.64 MΩ, N= 8; Dscamx3, 3.38 ± 0.7 MΩ,
N= 8; P= 0.823).
The amplitudes and intervals of mEJPs were compared by creating a
cumulative distribution for each genotype of 1600 measurements across
8 animals, with each animal contributing 200 values. To analyse the
mEJP waveform, a mean mEJP was constructed for each recording from
events that showed only a single clear peak and a smooth decay, which
prevented distortion of the waveform by closely occurring mEJPs. A
single exponential was ﬁtted to the decay of the mean mEJP and the
10–90% rise-time was measured. Time zero for the exponential ﬁt was
set to the time at the peak of the mEJP. EJP waveforms were analysed
by forming a mean EJP of 10 events, measuring the 10–90% rise-time of
the mean event, and ﬁtting the decay with the sum of three ex-
ponentials (time zero was set at the time of the peak). A mean weighted
time constant of decay (τdecay) was calculated as A1.τ1 + A2.τ2 + A3.τ3,
where A1, A2 and A3 are the fractional amplitudes of the three com-
ponents, and τ1, τ2 and τ3 are their time constants.
For paired pulse analysis, two EJPs were evoked with stimuli se-
parated by increasing intervals between 10 ms and 10 s. The second EJP
was measured and the amplitude of the second event was expressed as
fraction of the ﬁrst. Pairs of stimuli were separated by 30 s. For
high–frequency stimulation, trains of 10 EJPs were evoked at 10 Hz, 8
times at 1 min intervals. The amplitude of each event was expressed as
a fraction of the mean amplitude of 10 single EJPs evoked at 0.1 Hz
prior to the train (baseline). To investigate the eﬀect of the stimulus
trains on spontaneous release, 50 mEJPs per NMJ were analysed from
immediately before and immediately after the trains. Amplitudes and
inter-event intervals were measured and pooled from 8 NMJs to form
cumulative amplitude distributions composed of 400 values.
2.5. Statistical analysis
Statistical analysis was conducted in GraphPad Prism (v. 6, La Jolla,
CA). Data were tested for normality using the Kolmogorov-Smirnov
test; where appropriate, means were compared using Student's unpaired
t-test or medians were compared with a Mann-Whitney U test. Data are
given as mean ± SEM (standard error of the mean) or median. N is the
number of animals. Paired pulses and event trains were compared using
repeated measures 2-way ANOVA. Cumulative distributions were
compared with a Kolmogorov-Smirnov test. An α level of P < 0.05 was
considered statistically signiﬁcant.
3. Results
3.1. A third copy of Dscam altered basal spontaneous and evoked synaptic
transmission
The eﬀect of a third copy of the Dscam gene on synaptic transmis-
sion at a glutamatergic synapse was examined by making intracellular
microelectrode recordings at the NMJ of Dscamx3 Drosophila larvae
(Fig. 1A). Spontaneously occurring miniature excitatory junction po-
tentials (mEJPs) were smaller and more frequent than in control larvae
(CSw-) containing 2 copies of Dscam (Fig. 1B). In contrast to the re-
duction in mEJP amplitude, the amplitudes of electrically-evoked,
Ca2+-dependent excitatory junction potentials (EJPs) were unaltered
(Fig. 1C). Consequently, the approximate mean quantal content of EJPs
(calculated as mean EJP amplitude/mean mEJP amplitude for each
larva, not corrected for non-linear summation) was increased by 40%
(CSw-, 47.23 ± 3.41, N= 8; Dscamx3, 66.64 ± 7.47, N= 8;
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P= 0.0331). Therefore, an extra copy of Dscam caused a decrease in
the size of the postsynaptic depolarisations generated by single trans-
mitter vesicles (the mEJPs). In parallel, there was an increase in the
mean number of vesicles released by a nerve action potential which
resulted in an unchanged EJP amplitude. In addition, there was a
moderate lengthening of the decay of both mEJPs (by 29%) and EJPs
(by 25%) (Fig. 1D). The cause of the slower decay was not investigated.
3.2. A third copy of Dscam enhanced depression during high frequency
nerve stimulation
To examine further the impact of a third copy of Dscam on
Fig. 1. Basal synaptic transmission at Dscamx3 larval NMJs.
(A) Voltage recordings (3 s traces) from NMJs of Drosophila
larvae expressing the normal two (CSw-, black) or three
copies of Dscam1 (grey) illustrating spontaneously occur-
ring mEJPs at a membrane potential of −70 mV. (B)
Cumulative frequency distributions of mEJP amplitudes
(left) and intervals (right) (1600 events in each distribu-
tion; 200 from each of 8 NMJs). mEJPs at Dscamx3 NMJs
were smaller (P < 0.0001) and more frequent
(P < 0.0001). (C) (Left) Representative traces of a single
nerve-evoked EJP at a CSw- NMJ and a Dscamx3 NMJ.
(Right) The mean EJP amplitude did not diﬀer (CSw-,
47.37 ± 1.66 mV, N= 8; Dscamx3, 48.72 ± 1.08 mV,
N= 8; P= 0.5086). (D) (Left) Average waveform of EJPs,
formed from means of 10 events in 8 recordings. The mean
rise time was slower for Dscamx3 (CSw-, 2.27 ± 0.12 ms,
N= 8; Dscamx3= 2.62 ± 0.08 ms, N= 8; P= 0.036), as
was the decay (mean weighted τdecay of three exponentials
ﬁtted to the decay; CSw-, 31.00 ± 1.74 ms, N= 8;
Dscamx3= 38.60 ± 3.00 ms, N= 8; P= 0.0469).
(Right) Average waveform of mEJPs, superimposed and
normalised by the peak (grand average of mean mEJPs
constructed from 50 to 100 events from each of 8 record-
ings). The mean rise time did not diﬀer (CSw-,
6.24 ± 0.25 ms, N= 8; Dscamx3, 6.34 ± 0.52 ms,
N= 8; P= 0.816). The decay was slower for Dscamx3
(τdecay of a single exponential ﬁtted to the decay (not
shown): CSw-, 27.0 ± 1.73 ms, N= 8; Dscamx3,
34.9 ± 1.74 ms, N= 8; P= 0.006).
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electrically-triggered transmitter release, we compared synaptic plas-
ticity at Dscamx3 and control larval NMJs. In agreement with previous
studies at control NMJs, nerve stimulation with pairs of pulses at
varying intervals (between 10 ms and 10 s) caused depression of the
amplitude of the second EJP relative to the ﬁrst (Fig. 2A) (Dason et al.,
2009; Gaviño et al., 2015; Kauwe and Isacoﬀ, 2013). Such paired-pulse
depression also occurred at Dscamx3 NMJs, but it was more pro-
nounced, particularly at intervals shorter than 300 ms (Fig. 2A). The
strengthening of short-term synaptic depression at Dscamx3 NMJs be-
came clearer when EJPs were evoked by trains of stimuli applied in a
pattern that replicates burst ﬁring of Drosophila motoneurons (Kauwe
and Isacoﬀ, 2013). At control NMJs, each train (10 stimuli at 10 Hz)
caused a rapid decline in EJP amplitude of ~20% (Fig. 2B). The size of
the ﬁrst EJP of each of the 8 trains did not diﬀer, indicating full re-
covery during the one minute interval between trains (Fig. 2C). The
rapid decline and quick recovery are both in agreement with previous
studies of Drosophila larval NMJs which describe fast depletion of an
immediately releasable pool of vesicles and its fast replenishment
(Delgado et al., 2000; Kauwe and Isacoﬀ, 2013). At Dscamx3 NMJs, the
depression was enhanced to ~25% (Fig. 2B and C). It too was fast,
robust and short-lived, as its magnitude was constant from train to train
and there was full recovery of EJP amplitudes between trains (Fig. 2C).
Burst ﬁring of the nerve had no lasting eﬀect on spontaneous trans-
mitter release, as there was no diﬀerence in the distribution of mEJP
intervals (CSw-, P= 0.2905; Dscamx3, P= 0.4628) or amplitudes
(CSw-, P= 0.2796; Dscamx3, P= 0.9988) immediately before and
after the series of trains (400 events; 50 from each of 8 recordings,
recorded over ~20 s). Therefore, the extra copy of Dscam strengthened
short-term synaptic depression of action potential-dependent vesicular
release during high frequency ﬁring of the nerve but did not change the
speed of recovery.
3.3. A third copy of Dscam did not change the gross morphology of the NMJ
In adult Dscamx3 Drosophila, triplication of Dscam induces abnormal
branching of sensory axons and impaired transfer of information along
the neural circuit mediating touch perception (Cvetkovska et al., 2013),
while a gain of function mutation results in enlargement of nerve
terminals of C4 da neurons in Drosophila larvae (Kim et al., 2013). To
investigate if altered synaptic transmission at Dscamx3 larval NMJs was
Fig. 2. Synaptic depression is stronger at Dscamx3 larval NMJs. (A)
(Left) Representative pairs of stimulus evoked EJPs at control (CSw-,
black) and Dscamx3 (grey) NMJs. Dashed lines compare the ﬁrst EJP
(EJP1) and dotted lines compare the second EJP (EJP2). (Right) Plots
of paired-pulse ratio (EJP2/EJP1) against inter-pulse interval reveal
stronger depression at Dscamx3 NMJs (F (8, 112) = 2.245,
P= 0.0291). (B) High-frequency stimulation protocol. 10 EJPs were
evoked at 0.1 Hz to establish a mean baseline amplitude followed by
8 trains of 10 EJPs at 10 Hz, at one minute intervals. Representative
trains of EJPs recorded from CSw- and Dscamx3 NMJs. Dashed lines
compare EJP1 and dotted lines compare EJP8. (C) Plots of EJP am-
plitude during trains 1 (left) and 8 (right), expressed as a fraction of
baseline amplitude (vertical bars represent SEM). The depression in
EJP amplitude was greater at Dscamx3 NMJs than at control NMJs
during train 1 (F (9,126) = 3.98, P= 0.002) and train 8 (F (9,126)
= 3.86, P= 0.0002). The depression in amplitude was constant for
all trains within genotype (train 1 versus train 8: CSw- (F (9,126)
= 0.42, P= 0.9229; N= 8); Dscamx3 (F (9,126) = 1.23.
P= 0.2834, N= 8).
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accompanied by changes in the gross structure of motor nerve term-
inals, NMJs at muscles 6/7 were stained with ﬂuorescently-labelled
antibodies for horseradish peroxidase (HRP) and Discs-Large (Dlg). The
two motor neurons innervating the NMJ, one utilising type 1b (big) and
the other type 1 s (small) boutons, were discriminated by bouton size
and the greater expression of Dlg in the subsynaptic reticulum opposite
1b boutons (Menon et al., 2013). Analysis of stained NMJs revealed no
diﬀerence between control and Dscamx3 NMJs in the number of 1b or
1 s boutons (Fig. 3B) or the mean area of the muscle surface (CSw-,
87,771 ± 5307 μm2, N= 15; Dscamx3, 94,669 ± 4651 μm2, N= 15;
P= 0.3367). A minority of Dscamx3 NMJs (3/15) had one or two 1b
satellite boutons, composed of several smaller boutons budding from a
single larger central bouton (Menon et al., 2013), in contrast to the
usual linear arrangement (Fig. 3A).
3.4. A third copy of Dscam produced a locomotor impairment
Drosophila larvae crawl by peristaltic muscle contractions that are
driven by glutamate released from rhythmically ﬁring motoneurons
(Kohsaka et al., 2012). The possibility that the enhanced short-term
synaptic depression of glutamate release at Dscamx3 larval NMJs af-
fected movement was assessed in a simple crawling assay. This revealed
no eﬀect on the distance travelled in 1 min of free movement (Fig. 4A).
In contrast, performance was impaired in a self-righting assay (Fig. 4B),
which is a more complex locomotor task during which a larva needs to
perform a stereotyped sequence of movements to right itself after being
rolled onto its back (Picao-Osorio et al., 2015). These results show that
the extra copy of Dscam did not aﬀect general ﬁtness or the neural
circuits that control peristaltic muscle contractions, but it did impair
the correct operation of sensorimotor circuits that coordinate muscle
contractions underlying more complex movements (Kohsaka et al.,
2012).
4. Discussion
This study established that expression of a third copy of Drosophila
Dscam altered glutamatergic synaptic transmission at the larval NMJ.
The main presynaptically-mediated eﬀects were stronger short-term
depression of EJPs during burst ﬁring of motoneurons and a rise in the
frequency of spontaneous mEJPs. These changes were accompanied by
a decrease in mEJP amplitudes. The extra copy of Dscam also impaired
performance in a complex locomotor task.
Our ﬁndings that spontaneous transmitter release and short-term
plasticity of evoked transmitter release were altered at Dscamx3 larval
NMJs indicate that overexpression of Dscam can modify glutamatergic
synaptic transmission. DSCAM overexpression therefore may contribute
to brain dysfunction in DS, since DSCAM levels are increased in DS
brain (Alves-Sampaio et al., 2010; Saito et al., 2000) and mouse models
of DS (Alves-Sampaio et al., 2010; Amano et al., 2004; Jia et al., 2011;
Perez-Nunez et al., 2016). The increase in mEJP frequency, the absence
of a change in EJP amplitude despite a decrease in mEJP size and
stronger paired pulse depression, all suggest an increase in the basal
probability of glutamate release. This is reminiscent of the elevated
probability of glutamate release from cerebellar granule cells in the
Ts65Dn mouse model of DS (Das et al., 2013), but enhanced transmitter
released from these neurons is unlikely to be due to Dscam over-
expression as human cerebellar granule cells do not express DSCAM
(Saito et al., 2000). Our ﬁnding of a small but highly reproducible
strengthening of the depression of EJP amplitude by high frequency
stimuli trains suggests an enlargement in the size of the readily re-
leasable pool of neurotransmitter vesicles (Kavalali, 2015), perhaps to
facilitate an increase in quantal content of the EJP and thus maintain its
Fig. 3. Bouton number is unchanged at Dscamx3 larval
NMJs. (A) Representative images of CSw- and Dscamx3
larval NMJs at muscle 6/7 in abdominal section 2, stained
for horseradish peroxidase (green) and Discs large (ma-
genta). Arrowheads point to type 1 s (small) boutons
(green) and type 1b (big) boutons (green and magenta).
Circle indicates a satellite 1b bouton composed of a central
bouton surrounded by multiple smaller boutons. (B)
Comparison of the number of 1b (left) and 1s (right) bou-
tons. There was no diﬀerence in the mean number between
control and Dscamx3 NMJs (1b boutons: CSw-,
24.93 ± 1.11, N= 15; Dscamx3, 28.8 ± 1.69, N= 15;
P= 0.0883; 1s boutons: CSw-, 32.6 ± 2.62., N= 15;
Dscamx3, 32.83 ± 3.42, N= 15; P= 0.786).
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amplitude, in response to the decrease in mEJP amplitude
(Weyhersmuller et al., 2011). The modest slowing of the mEJP and EJP
decays resembles the slowing of evoked EPSCs at cerebellar parallel
ﬁbre-Purkinje cell synapses of Tc1 mice (Galante et al., 2009), which
could reﬂect Dscam overexpression in the parallel ﬁbres or the Purkinje
cells as DSCAM is known to be overexpressed in ﬁbres of the cerebellar
granule layer and in cerebellar Purkinje cells of DS brain (Saito et al.,
2000).
Other previous studies of glutamatergic transmission in the Ts65Dn
mouse model of DS have reported results that contradict our ﬁndings.
They have found a reduction, and not the increase we observed, in the
frequency of mEPSCs in hippocampal CA3 neurons (Hanson et al.,
2007; Roncace et al., 2017), sEPSCs in neocortical neurons of Ts65Dn
mice (Cramer et al., 2015) and sEPSCs in neurons derived from trisomy
21 induced pluripotent stem cells (Weick et al., 2013). Another study
found speeding, and not the slowing we observed, of mEPSC waveform
in cultured Ts65Dn hippocampal neurons (Best et al., 2008). The dif-
ferences between the previous results and our ﬁndings could indicate
that overexpression of Dscam alone does not cause the changes in sy-
naptic function seen in DS mouse models and that triplication of other
HSA21 gene orthologues is necessary. They could also indicate that
synaptic function is diﬀerentially altered at diﬀerent brain synapses in
DS and that the eﬀects at the glutamatergic synapse of Drosophila larvae
model changes at brain synapses other than those in the hippocampus
or neocortex. Moreover, a confounding factor in studies using Ts65Dn
mice is the triplication of an additional ~35 protein coding genes
which are not orthologous to HSA21 genes, but which may have
modiﬁed the eﬀects of the 90 HSA21 orthologues triplicated in Ts65Dn
(Gupta et al., 2016). Also, Ts65Dn mice are trisomic for only ~55% of
the HSA21 orthologues. Therefore, in order to better understand the
changes in glutamatergic transmission in DS and their genetic basis,
and to allow a comparison between our results using Drosophila with
mouse models of DS, it would be informative to study synaptic function
in the brain of multiple genetic mouse models of DS that do not have
three copies of other, non-HSA21, orthologues.
The eﬀects of Dscam overexpression on glutamatergic transmission
that we observed occurred in the absence of gross changes in the
structure of motor nerve terminals, as indicated by the unaﬀected
numbers of boutons. This was unexpected as Dscam controls dendritic
and axonal branching, and the precise apposition of presynaptic and
postsynaptic elements, in mice and Drosophila (Alves-Sampaio et al.,
2010; Andrews et al., 2008; Cvetkovska et al., 2013; Fuerst et al., 2009;
Jain and Welshhans, 2016; Kim et al., 2013; Li et al., 2015). However,
modiﬁcations in the ﬁne structure of the NMJs cannot be excluded, as
the lengthening of the synaptic events could reﬂect impeded clearance
of glutamate from the synaptic cleft (Li et al., 2009). The eﬀects on
spontaneous transmission and short-term depression were relatively
modest. Nevertheless, their sum impact across a population of synapses
would be of suﬃcient magnitude to aﬀect information processing. It is
also possible that the eﬀects on transmitter release are not limited to
glutamatergic synapses but apply to the release of GABA from neurons
such as GABAergic cerebellar Purkinje cells, which overexpress DSCAM
in DS (Saito et al., 2000). This would aﬀect motor function as Purkinje
cells are the sole output of the cerebellar cortex (Apps and Garwicz,
2005).
The mechanisms by which the extra copy of Dscam aﬀected multiple
aspects of synaptic transmission remain to be elucidated. The eﬀects
could be due to a primary eﬀect of Dscam overexpression in the motor
nerve terminals or they could be compensatory responses to the smaller
mEJP amplitude. In turn, the decrease in mEJP amplitude could reﬂect
a lower vesicular concentration of glutamate or changes in the prop-
erties of the postsynaptic glutamate receptors, since both presynaptic
and postsynaptic Dscam inﬂuences the arrangement of postsynaptic
ionotropic glutamate receptors in Aplysia neurons (Li et al., 2009). We
do not know if the eﬀects were due to Dscam overexpression pre-
synaptically, in the motor nerve terminals, or postsynaptically, in the
muscle, or both. Previous studies have shown that Drosophila Dscam is
expressed broadly in the developing and adult nervous system and lo-
calises to dendrites, axons and presynaptic terminals (Hummel et al.,
2003; Hutchinson et al., 2014; Kim et al., 2013; Millard et al., 2010;
Wang et al., 2004; Zhu et al., 2006); it has also been suggested to be
expressed in larval muscle (Carrero-Martínez and Chiba, 2009). How-
ever, deﬁnitive mapping of the presence or absence of Dscam isoforms
to presynaptic or postsynaptic elements of the larval NMJ is
Fig. 4. A third copy of Dscam slows self-righting behaviour. (A) Sample movement trajectories of CSw- (black) and Dscamx3 (grey) third instar larvae. Number of lines (0.5 cm spacing)
crossed did not diﬀer (CSw-, 13.8 ± 0.27, N= 15; Dscamx3, 13.27 ± 0.43, N= 15; P= 0.323). (B) Sequence of movements performed by a larva during self-righting after being
placed on its back with a ﬁne brush. Dscamx3 larvae took longer to complete the movements (CSw-, 6.87 ± 1.18 s, N= 15; Dscamx3, 25.27 ± 3.6 s, N= 15; P= 0.0002).
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problematic due to extensive alternative splicing of Dscam, which
consists of four clusters of 12, 48, 33 and 2 mutually exclusive exons
that can form in excess of 38,000 protein isoforms, in a cell-speciﬁc
manner (Schmucker, 2007).
The selective eﬀect of Dscam overexpression on Drosophila neural
circuits that control larval self-righting behaviour, without an eﬀect on
crawling speed, mirrors the more severe disruption of ﬁne rather than
gross motor skills of people with DS (Ferreira-Vasques and Lamônica,
2015; Marchal et al., 2016; Schott and Holfelder, 2015; Spanò et al.,
1999). Likewise, a number of mouse models trisomic for regions of
murine chromosomes orthologous to HSA21, which include Dscam,
show no deﬁcits in gross motor ability but are impaired in assays re-
quiring balance and locomotor coordination (Belichenko et al., 2009;
Goodliﬀe et al., 2016; Sago et al., 1998). Further evidence for the im-
portance of the correct dosage of Dscam in determining optimal motor
function is the disturbed locomotor coordination, despite largely spared
walking ability, of Dscam loss-of-function mice (Lemieux et al., 2016;
Thiry et al., 2016; Xu et al., 2011). In these mice, there is aberrant
development of locomotor and sensorimotor circuits as well as en-
hanced depression of nerve-evoked potentials in skeletal muscle during
high frequency stimulation of motor nerves, akin to the stronger sy-
naptic depression we observed at Dscamx3 larval NMJs (Lemieux et al.,
2016). Similarly, RNAi-mediated knockdown of Dscam causes motor
impairment in the beetle T. castaneum (Peuß et al., 2016), further in-
dicating a conserved role across species. Altogether, these previous
studies and our current study suggest that DSCAM overexpression in DS
may contribute to motor disabilities experienced by people with DS.
5. Conclusions
This study shows that expression of a third copy of Dscam, a
homologue of one of the genes on HSA21, was suﬃcient to modify
synaptic function and disrupt locomotor performance in the model or-
ganism Drosophila. This novel evidence further elucidates the function
of DSCAM. Further work is required to fully describe the role(s) of
DSCAM overexpression in DS, particularly in the context of concomitant
overexpression of other HSA21 genes.
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